Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMuneâ„¢ and Ivermectin in Animal Models of COVID-19 Pathology

Author's Avatar
Sep 16, 2021

Company Developing Phase III Stem Cell Therapy for COVID-19 Advances Natural Approaches Towards Controlling Pandemic

PR Newswire